Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Narazaciclib + Dexamethasone in Relapsed/Refractory Multiple Myeloma
NCT06351644Phase 2Terminated
- Start
- Oct 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of narazaciclib in multiple myeloma (MM). Started Oct 2024; status: terminated.
02
Drugs
narazaciclib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT06351644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06351644.